STOCK TITAN

Sono-Tek Reports Fiscal Fourth Quarter and Full Year 2026 Financial Results

(Very Positive)
Tags

Sono-Tek (Nasdaq:SOTK) reported fiscal 2026 net sales of $20.9 million, up 2%, with gross margin rising to 51%. Operating income grew 81% to $1.83 million and net income rose 42% to $1.81 million.

Q4 2026 sales were $5.6 million, net income $0.56 million, cash was $14.8 million with no debt, and backlog reached about $9.1 million. Medical revenue increased 54%, electronics 16%, while alternative/clean energy declined 19%. The company projects flat to modestly higher revenue in FY 2027.

Loading...
Loading translation...

Positive

  • FY 2026 net sales rose 2% to $20.9 million
  • Gross margin expanded to 51% from 48% year over year
  • Operating income increased 81% to $1.83 million, 9% margin
  • Net income grew 42% to $1.81 million, 9% margin
  • Q4 2026 net sales up 10% to $5.6 million
  • Cash and marketable securities of $14.8 million with no debt
  • Backlog increased 5% to about $9.1 million, near record levels
  • Medical end market revenue up 54% year over year
  • Electronics end market revenue up 16% year over year
  • In-line coating system sales increased 91%, including eight high-ASP solar systems
  • Fluxing system sales grew 53%, driven by Asia

Negative

  • Alternative/clean energy revenue declined 19% year over year
  • Multi-axis systems declined due to lower electrolysis-related demand
  • Electrolysis demand reduced by government policy shifts and incentive cuts
  • FY 2027 full-year revenue expected only flat to modestly higher
  • Visibility beyond first half FY 2027 remains limited
  • Timing of high-ASP orders may cause significant quarterly revenue variability

News Market Reaction – SOTK

-8.47%
7 alerts
-8.47% Session close to close
+4.3% Peak Tracked
-18.3% Trough Tracked
$83.42M Market Cap
1.1x Rel. Volume

In the May 28 session, SOTK declined 8.47%, reflecting a notable negative market reaction. Argus tracked a peak move of +4.3% during that session. Argus tracked a trough of -18.3% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved -8.5% in the session following this news. A negative reaction despite improved FY202...
Analysis

The stock moved -8.5% in the session following this news. A negative reaction despite improved FY2026 profitability would fit a pattern where prior earnings, despite better margins and income, saw an average move of -1.58%. The results feature net sales of $20.9M, a 51% gross margin, and net income up 42%, but guidance for relatively flat FY2027 revenue and clean energy uncertainty could have overshadowed the operational gains.

Key Figures

FY2026 Net Sales: $20.9M FY2026 Gross Margin: 51% FY2026 Operating Income: $1.825M +5 more
8 metrics
FY2026 Net Sales $20.9M Up 2% from $20.5M in FY2025
FY2026 Gross Margin 51% Up from 47.5% in FY2025
FY2026 Operating Income $1.825M Up 81% from $1.01M in FY2025
FY2026 Net Income $1.806M Up 42% from $1.273M in FY2025
Year-end Cash & Securities $14.8M Cash, cash equivalents and marketable securities; no debt
Year-end Backlog $9.12M Up 5% from $8.67M; near record level
Q4 FY2026 Net Sales $5.609M Up 10% from $5.121M in Q4 FY2025
Q4 FY2026 Net Income $557K Up 70% from $328K in Q4 FY2025

Previous Earnings Reports

5 past events · Latest: Jan 13 (Positive)
Same Type Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jan 13 Q3 FY2026 earnings Positive -0.5% Q3 margins reached 50% and net income rose 24% on flat revenue.
Oct 14 Q2/H1 FY2026 earnings Positive -3.6% Record first-half revenue, higher margins, and strong medical-driven backlog.
Jul 10 Q1 FY2026 earnings Positive -0.5% Fifth straight quarter above $5M sales with sharp income and margin gains.
May 28 FY2025 results Neutral +0.6% Record FY2025 revenue but softer margins and slightly lower net income.
Jan 13 Q3/Nine-month FY2025 Negative -4.0% Q3 sales and margins declined even as nine‑month revenue hit a record.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Earnings releases for SOTK have often seen modestly negative or muted next-day moves despite generally improving margins and profitability, with an average move of -1.58% around prior earnings updates.

Recent Company History

Recent earnings reports show SOTK steadily growing profitability on relatively flat revenue. Prior updates highlighted consecutive quarters above $5M sales, gross margin around 50–51%, rising net income, and a solid cash position with no debt. Backlog has remained strong, supporting visibility into future revenue. Today’s FY2026 results extend that pattern with higher margins, operating leverage, and continued focus on high-ASP systems, while management reiterates a cautious outlook on clean energy exposure.

Key Terms

ultrasonic coating systems, stent coating, balloon catheter, electrolysis, +2 more
6 terms
ultrasonic coating systems technical
"Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported"
Ultrasonic coating systems are manufacturing machines that use high‑frequency vibrations to turn liquids into extremely fine droplets, then lay them down as thin, even films on products like electronics, medical devices, or packaging. For investors, they matter because the technology can improve product performance and yield while cutting material waste and production costs—think of painting with a fine, precise spraygun instead of a messy brush—so companies using it may gain quality or efficiency advantages.
stent coating medical
"growing demand across applications such as stent coating, balloon catheter systems, and diagnostic devices."
A stent coating is a thin layer of material applied to the surface of a tube placed inside a blood vessel to control how the device interacts with blood and surrounding tissue. Coatings can prevent clotting, reduce inflammation or release drugs over time, so they directly affect patient safety, regulatory approval, product differentiation and potential sales—think of it like a protective paint that changes performance and market value.
balloon catheter medical
"growing demand across applications such as stent coating, balloon catheter systems, and diagnostic devices."
A balloon catheter is a thin medical tube with a small inflatable balloon near its tip that doctors guide into blood vessels or other body passages to widen a blockage, position implants, or deliver treatments. For investors, it matters because sales, regulatory approval, or safety issues for these devices can directly affect a medical device maker’s revenue and growth, much like a popular tool driving demand for a construction company.
electrolysis technical
"near-term orders for electrolysis-related systems have declined, mirroring softening demand"
Electrolysis is a process that uses an electric current to drive a chemical change, commonly splitting a compound into simpler substances—most often separating water into hydrogen and oxygen. Investors care because electrolysis underpins technologies like clean hydrogen production, certain metal refining and industrial processes, and some medical devices; its efficiency, cost and scale can directly affect a company’s expenses, revenue potential and regulatory profile, much like the productivity of a factory machine determines output and margins.
thin films technical
"used to apply thin films onto parts used in diverse industries including microelectronics"
Thin films are extremely thin layers of material—often thousands to millions of times thinner than a sheet of paper—applied to surfaces to give specific electrical, optical or protective properties. Investors care because these coatings can determine how well products work, how cheaply they can be made and whether a company holds valuable manufacturing know‑how or patents; think of them like a high‑performance coat of paint that can make or break a technology’s competitiveness.
stock options financial
"He exercised options into Sono-Tek Corp Common Stock at prices of $5.48, $4.45, and $4.12 per share."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Reports Second Consecutive Year of over $20 Million in Revenue and Eighth Consecutive Quarter above $5 Million

Significant Profitability Expansion with 51% Gross Margin for FY 2026

FY 2026 Operating Income Increased 81% and Net Income Increased 42% Year-Over-Year

Backlog Remains Strong at $9.1 Million

Anticipating Continued Revenue Growth in 1H 2027 Driven by Strong Medical Sector and High-ASP Systems

Conference call scheduled for 10:30 AM ET Today

MILTON, N.Y., May 28, 2026 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the fiscal fourth quarter and full fiscal year 2026, ended February 28, 2026.

Steve Harshbarger, CEO & President of Sono-Tek, stated:
“We are greatly encouraged by our fiscal 2026 results, highlighted by strong profitability expansion and uninterrupted revenue consistency. We achieved our second consecutive year of revenue over $20 million and eighth consecutive quarter of revenue above $5 million, reflecting the durability and stability of our business. Additionally for FY 2026, our gross margin increased to 51%, operating income increased 81%, and net income grew by 42%, demonstrating the strength of our business model and the continuing success of our strategy focused on higher-value, high-ASP production systems.”

“Margin expansion in the year was driven primarily by favorable product mix, including a higher concentration of high-ASP production systems, as well as a greater percentage of sales in the U.S. market, where we benefit from stronger margins by bypassing international-business costs.”

“We are seeing strong momentum in the medical sector, with growing demand across applications such as stent coating, balloon catheter systems, and diagnostic devices. In addition, our electronics business continues to expand, particularly in electrically active coatings for diagnostic-related applications that leverage our core coating technologies. While clean energy remains an important long-term opportunity, near-term orders for electrolysis-related systems have declined, mirroring softening demand that has resulted from government policy changes and elimination of incentives. This was partially offset by solar system shipments earlier in the fiscal year.”

“Looking ahead, we anticipate continued revenue growth in the first half of FY 2027 and profitability driven by the medical sector and sustained demand for high-ASP production systems. For FY 2027, we anticipate relatively flat to modestly higher year over year revenue, with continued uncertainty in certain clean energy sectors and the timing of high ASP customer orders, that are more complex and typically involve longer lead times.

We believe our strategy is succeeding, and we remain confident in our ability to deliver long-term revenue growth and profitability.”

Dr. Christopher L. Coccio, Executive Chairman, added:

“We are pleased with the Company’s continued execution and improving financial performance. We are proud to report that FY 2026 marks our third consecutive year of annual revenue growth and sixteenth year in a row of profitability. Our strong backlog, supported by demand for complex, production-oriented systems, provides a solid foundation as we move forward. Sono-Tek’s ability to adapt to changing market conditions, while maintaining focus on high-value opportunities, continues to differentiate the Company. We remain confident in our long-term strategy and growth trajectory.”

Fiscal Year 2026 Highlights

  • Net Sales: $20.9 million, up 2% from $20.5 million in FY 2025, reflecting continued demand for high-ASP production systems and growth in medical and electronics markets.

  • Gross Profit: $10.56 million, up 8% from $9.74 million in the prior year. Gross margin increased to 51% from 47.5%, driven by favorable product mix and increased U.S.-based system sales.

  • Operating Income: $1.82 million, up 81% from $1.01 million in FY 2025, reflecting improved operating leverage and higher-margin system shipments.

  • Net Income: Approximately $1.8 million, up 42% from $1.27 million in FY 2025, reflecting strong margin expansion and improved profitability.

Fiscal 2026 Review   (Results compared with fiscal 2025)
($ in thousands)    
   Change
 FY 2026FY 2025$%
Net Sales$20,909 $20,504 4052%
Gross Profit$10,560 $9,739 8218%
Gross Profit 51%  48%  3%
     
Operating Income$1,825 $1,010 81581%
Operating Margin 9%  5%  4%
     
Net Income$1,806 $1,273 53342%
Net Margin 9%  6%  2%


Fourth Quarter Fiscal 2026 Highlights

  • Net Sales: $5.6 million, up 10% from $5.12 million in Q4 FY 2025.

  • Gross Profit: $2.79 million, up 15% from $2.43 million in the prior-year period, with gross margin increasing to 50%.

  • Net Income: $557,043, up 70% from $327,714 in Q4 FY 2025.

Fourth Quarter Fiscal 2026 Review(Results compared with the fourth quarter offiscal 2025)
($ in thousands)    
   Change
 FY 2026FY 2025$%
Net Sales$5,609 $5,121 48810%
Gross Profit$2,793 $2,425 36815%
Gross Profit 50%  47%  3%
     
Operating Income (Loss)$601 $288 313109%
Operating Margin 11%  6%  5%
     
Net Income$557 $328 22970%
Net Margin 10%  6%  4%


Balance Sheet, Backlog and Outlook

Balance Sheet: The Company ended the fiscal year with $14.8 million in cash, cash equivalents and marketable securities and no outstanding debt.

Backlog: Equipment and service-related backlog remained strong at approximately $9.12 million at fiscal year-end, an increase of 5% compared to $8.67 million at the end of FY 2025, and near record levels.

Outlook: Sono-Tek anticipates continued revenue growth and profitability in the first half of fiscal year 2027 compared to the first half of FY 2026, driven by expanding demand in the medical sector and continued adoption of high-ASP, production-scale coating systems across multiple end markets. Total FY 2027 revenue is currently projected to be relatively flat to modestly higher compared to FY 2026 as visibility beyond the first half remains limited due to continued uncertainty in certain clean energy sectors and the timing of high ASP customer orders, which can create significant shifts in quarterly delivery timing.

Fiscal Year 2026 Product and Market Highlights

End Markets:

  • Medical: Increased 54%, driven by strong demand for balloon catheter coating systems, specialty stent applications, and expanding activity in new medical applications. 

  • Electronics: Increased 16%, supported by strong demand for electrically active coatings in diagnostic-related applications. 

  • Alternative/Clean Energy: Declined 19% due to reduced electrolysis demand driven by government policy shifts, partially offset by solar system shipments earlier in the fiscal year. 

Product Categories:

  • In-Line Coating Systems (formerly referred to as Integrated Coating Systems): Increased 91%, driven by shipments of eight high-ASP systems to a solar customer. 

  • Fluxing Systems: Increased 53%, supported by strong sales in Asia. 

  • Multi-Axis Systems: Declined due to reduced demand in electrolysis-related applications. 

Conference Call Dial-in Information

To participate, please call 1-844-481-2752 or 1-412-317-0668 for international callers at least 10 minutes prior to the start of the call and ask to join the Sono-Tek call.

A simultaneous webcast of the call may be accessed through the Company's website, Events & Presentations | Sono-Tek or at:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=6cEJqpHo

A replay of the call will be available at 1-855-669-9658 or 1-412-317-0088 for international callers, access code 7754993, through June 4, 2026. A replay of the call will also be available on the Company’s website for one year at www.sono-tek.com.

About Sono-Tek

Sono-Tek Corporation is a global leader in the design and manufacture of ultrasonic coating systems that are shaping industries and driving innovation worldwide. Our ultrasonic coating systems are used to apply thin films onto parts used in diverse industries including microelectronics, alternative energy, medical devices, advanced industrial manufacturing, and research and development sectors worldwide. Sono-Tek's inroads into the clean energy sector have shown transformative results in next-gen solar cells, fuel cells, green hydrogen generation, and carbon capture applications.

Our product line is rapidly evolving, transitioning from R&D to high-volume production machines with significantly higher average selling prices, showcasing our market leadership and adaptability. Our comprehensive suite of thin film coating solutions and application consulting services are expected to generate unparalleled results for our clients and help some of the world's most promising companies achieve technological breakthroughs and bring them to the market. We strategically deliver our products to customers through a network of direct sales personnel, carefully chosen independent distributors, and experienced sales representatives, ensuring efficient market reach across diverse sectors around the globe.

Our solutions are environmentally friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

Our growth strategy is focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further develop thin film coating technologies that enable better outcomes for our customers’ products and processes. For further information, visit www.sono-tek.com

Safe Harbor Statement

This news release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These “forward-looking statements’ are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions, including political, regulatory, tax, competitive and technological developments affecting our operations or the demand for our products; inflationary and supply chain pressures; continued strength of sales to the medical device and electronics markets; continued private and public funding for the clean energy sector; continued strong demand for Sono-Tek’s suite of thin film coating solutions and application consulting services in the clean energy and other markets; maintenance of order backlog; evolving tariff policies; timely development and market acceptance of new products and continued customer validation of our coating technologies; adequacy of financing; capacity additions, the ability to enforce patents; maintenance of operating leverage; consummation of order proposals; timing of large orders and completion on schedule and on budget; successful transition from primarily selling ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems; and realization of first half and annual revenues and profitability within the forecasted ranges of guidance. We undertake no obligation to update any forward-looking statement.

For more information:

Sono-Tek Corp.
Stephen J. Bagley
Chief Financial Officer
Ph: (845) 795-2020
info@sono-tek.com

Investor Relations
Kirin Smith, President
PCG Advisory, Inc.
ksmith@pcgadvisory.com

- Financial Tables to follow –


SONO-TEK CORPORATION
CONSOLIDATED BALANCE SHEETS
 
   February 28,
2026
  February 28,
2025
 
ASSETS         
Current Assets:         
Cash and cash equivalents  $7,339,403  $5,202,361  
Marketable securities   7,469,649   6,727,678  
Accounts receivable (less allowance for credit losses of $12,225, respectively)   3,350,953   2,347,764  
Inventories   3,923,350   4,474,401  
Prepaid expenses and other current assets   743,295   236,261  
Total current assets   22,826,650   18,988,465  
          
Land   250,000   250,000  
Buildings, equipment, furnishings and leasehold improvements, net   2,173,443   2,610,600  
Intangible assets, net   29,791   37,386  
Deferred tax asset   1,141,611   1,525,185  
          
TOTAL ASSETS  $26,421,495  $23,411,636  
          
LIABILITIES AND STOCKHOLDERS’ EQUITY         
          
Current Liabilities:         
Accounts payable  $1,038,885  $859,483  
Accrued expenses   2,227,401   1,718,574  
Customer deposits   3,069,743   2,413,195  
Income taxes payable   255,398   496,055  
Total current liabilities   6,591,427   5,487,307  
          
Deferred tax liability   55,909   132,134  
          
Total Liabilities   6,647,336   5,619,441  
          
Commitments and Contingencies (Note 13)         
          
Stockholders’ Equity         
Common stock, $.01 par value; 25,000,000 shares authorized, 15,751,153 issued and 15,749,037 outstanding as of February 28, 2025, and 15,750,880 issued and outstanding as of February 29, 2024   157,104   157,512  
Additional paid-in capital   10,186,858   10,018,034  
Accumulated earnings   9,430,197   7,624,516  
Treasury stock, at cost, 2,116 shares   -   (7,867) 
          
Total stockholders’ equity   19,774,159   17,792,195  
          
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $26,421,495  $23,411,636  


 
SONO-TEK CORPORATION
CONSOLIDATED STATEMENTS OF INCOME
 
   February 28,
2026
  February 28,
2025
 
        
Net Sales  $20,909,315  $20,504,381 
Cost of Goods Sold   10,349,373   10,765,362 
Gross Profit   10,559,942   9,739,019 
          
Operating Expenses         
Research and product development   2,553,898   2,724,482 
Marketing and selling   3,525,239   3,677,915 
General and administrative   2,655,836   2,326,582 
Total Operating Expenses   8,734,973   8,728,979 
          
Operating Income   1,824,969   1,010,040 
          
Other Income:         
Interest and dividend income   443,588   488,504 
Net unrealized gain on marketable securities   (1,498)  35,548 
Income before Income Taxes   2,267,059   1,534,092 
          
Income Tax Expense   461,378   260,678 
          
Net Income  $1,805,681  $1,273,414 
          
Basic Earnings Per Share  $0.11  $0.08 
          
Diluted Earnings Per Share  $0.11  $0.08 
          
Weighted Average Shares – Basic   15,718,796   15,750,997 
          
Weighted Average Shares – Diluted   15,733,825   15,770,102 


 
SONO-TEK CORPORATION
PRODUCT, MARKET, AND GEOGRAPHIC SALES
(Unaudited)
 
Product Sales:       
  Twelve Months Ended     
  February 28,  % of  February 28,  % of  Change 
  2026  Total  2025  total  $  % 
Fluxing Systems $713,000  3%  $467,000  2%  $246,000  53% 
In-Line Coating Systems  7,070,000  34%   3,703,000  18%   3,367,000  91%  
Multi-Axis Coating Systems  8,055,000  39%   10,678,000  52%   (2,623,000) (25%)  
OEM Systems  1,210,000  6%   1,484,000  7%   (274,000) (18%)  
Other  3,861,000  18%   4,172,000  21%   (311,000) (7%)  
TOTAL $20,909,000     $20,504,000     $405,000  2%  


Market Sales:       
  Twelve Months Ended     
  February 28,  % of  February 29,  % of  Change 
  2026  Total  2025  total  $  % 
Electronics/Microelectronics $6,290,000  30%  $5,426,000  27%  $864,000  16% 
Medical  5,004,000  24%   3,250,000  16%   1,754,000  54%  
Alternative Energy  7,974,000  38%   9,838,000  48%   (1,864,000) (19%)  
Emerging R&D and Other  66,000  0%   67,000  0%   (1,000) (1%)  
Industrial  1,575,000  8%   1,923,000  9%   (348,000) (18%)  
TOTAL $20,909,000     $20,504,000     $405,000  2%  


Geographic Sales:       
  Twelve Months Ended     
  February 28,  February 28,  Change 
  2026  2026  $  % 
U.S. & Canada $13,946,000  $12,506,000  $1,440,000  12% 
Asia Pacific (APAC)  2,630,000   2,758,000   (128,000) (5%)  
Europe, Middle East, Africa (EMEA)  3,742,000   4,431,000   (689,000) (16%)  
Latin America  591,000   809,000   (218,000) (27%)  
TOTAL $20,909,000  $20,504,000  $405,000  2%  

FAQ

How did Sono-Tek (Nasdaq:SOTK) perform in its fiscal 2026 earnings results?

Sono-Tek reported higher fiscal 2026 revenue and profitability, with net sales of $20.9 million and net income of $1.81 million. According to the company, gross margin rose to 51%, operating income increased 81%, and net income grew 42% versus fiscal 2025.

What were Sono-Tek’s key financial highlights for Q4 fiscal 2026 (SOTK)?

Sono-Tek’s Q4 fiscal 2026 net sales were $5.6 million, with net income of about $0.56 million. According to the company, quarterly sales rose 10%, gross profit increased 15%, gross margin reached 50%, and operating income more than doubled compared with Q4 fiscal 2025.

How strong is Sono-Tek’s balance sheet and backlog after fiscal 2026?

Sono-Tek ended fiscal 2026 with $14.8 million in cash, cash equivalents and marketable securities, and no debt. According to the company, equipment and service backlog was about $9.12 million, up 5% year over year and described as near record levels.

Which end markets drove Sono-Tek’s revenue growth in fiscal 2026 (SOTK)?

Medical and electronics end markets drove Sono-Tek’s fiscal 2026 growth, while clean energy declined. According to the company, medical revenue rose 54% and electronics increased 16%, while alternative/clean energy revenue fell 19% due to weaker electrolysis demand partially offset by solar shipments.

How did Sono-Tek’s product categories perform in fiscal 2026 (Nasdaq:SOTK)?

Sono-Tek saw strong gains in in-line and fluxing systems, with weakness in multi-axis systems. According to the company, in-line coating systems increased 91%, fluxing systems grew 53%, while multi-axis systems declined due to reduced electrolysis-related applications demand.

What factors drove Sono-Tek’s gross margin expansion to 51% in fiscal 2026?

Sono-Tek’s gross margin improved to 51% in fiscal 2026, up from about 48% a year earlier. According to the company, favorable product mix with more high-ASP production systems and higher U.S. sales, which bypass certain international costs, supported this margin expansion.